Produções Científicas

ARTIGOS PUBLICADOS EM REVISTAS CIENTÍFICAS INTERNACIONAIS

2019

CASP8 (rs3834129) and CASP3 (rs4647601) polymorphisms in oropharynx cancer risk, tumor cell differentiation, and prognosis in a cohort of the Brazilian population

Tortorelli GA, Torricelli C, Carron J, Costa EFD, Lopes-Aguiar L, Carvalho BF, Rinck-Junior JA, Mariano FV, Altemani AMAM, Lima CSP, Lourenço GJ.

Mol Biol Rep. 2019 Oct 5. doi: 10.1007/s11033-019-05107-9. PMID: 31587185

**Associations of VEGFA and KDR single-nucleotide polymorphisms and increased risk and aggressiveness of high-grade gliomas**

Vasconcelos VCA, Lourenço GJ, Brito ABC, Vasconcelos VL, Maldaun MVC, Tedeschi H, Marie SKN, Shinjo SMO, Lima CSP.

Tumour Biol. 2019 Sep;41(9):1010428319872092. doi: 10.1177/1010428319872092. PMID: 31486713

Bioinformatics analysis of circulating miRNAs related to cancer following spinal cord injury

Lopes ECP, Paim LR, Matos-Souza JR, Calegari DR, Gorla JI, Cliquet A Jr, Lima CSP, McDonald JF, Nadruz W Jr, Schreiber R.

Biosci Rep. 2019 Sep 20;39(9). pii: BSR20190989. doi: 10.1042/BSR20190989. PMID: 31444279

Novel anticancer PdII complexes: The effect of the conjugation of transferrin binding peptide and the nature of halogen coordinated on antitumor activity

Teles CM, Lammoglia LC, Juliano MA, Ruiz ALTG, Candido TZ, de Carvalho JE, Lima CSP, Abbehausen C.

J Inorg Biochem. 2019 Oct;199:110754. doi: 10.1016/j.jinorgbio.2019.110754. PMID: 31401348

Increased risk of Hodgkin lymphoma in males with inherited T lymphocyte receptor programed death-1 deficiency

Delamain MT, Gomez GVB, Lourenço GJ, de Souza CA, Lima CSP.

Leuk Lymphoma. 2019 Jul 8:1-5. doi: 10.1080/10428194.2019.1636988. PMID: 31282791

GSTM1, GSTT1 and GSTP1 Ile105Val polymorphisms in outcomes of head and neck squamous cell carcinoma patients treated with cisplatin chemoradiation

Pincinato EC, Costa EFD, Lopes-Aguiar L, Nogueira GAS, Lima TRP, Visacri MB, Costa APL, Lourenço GJ, Calonga L, Mariano FV, Altemani AMAM, Coutinho-Camillo C, Chone CT, Ramos CD, Altemani JMC, Moriel P, Lima CSP.

Sci Rep. 2019 Jun 27;9(1):9312. doi: 10.1038/s41598-019-45808-6. PMID: 31249357

Can acetylcysteine ameliorate cisplatin-induced toxicities and oxidative stress without decreasing antitumor efficacy? A randomized, double-blind, placebo-controlled trial involving patients with head and neck cancer

Visacri MB, Quintanilha JCF, de Sousa VM, Amaral LS, de F L Ambrósio R, Calonga L, Curi SFBB, de T Leme MF, Chone CT, Altemani JMC, Mazzola PG, Malaguti C, Vercesi AE, Lima CSP, Moriel P.

Cancer Med. 2019 May;8(5):2020-2030. doi: 10.1002/cam4.2072. PMID: 30977273

CASP9 c.-1339A>G and CASP3 c.-1191A>G polymorphisms alter susceptibility and clinical aspects of head and neck squamous cell carcinoma

Costa EFD, Lopes-Aguiar L, Nogueira GS, Lima TRP, Rinck-Junior JA, Lourenço GJ, Lima CSP.

Head Neck. 2019 Aug;41(8):2665-2670. doi: 10.1002/hed.25746. PMID: 30903678

Primary infratentorial diffuse large b-cell lymphoma: a challenging diagnosis in an immunocompetent patient

Beraldo GL, Brito ABC, Delamain MT, Souza CA, Lima CSP, Bonfitto JFL, Queiroz LS, Reis F.

Rev Assoc Med Bras (1992). 2019 Feb;65(2):136-140. doi: 10.1590/1806-9282.65.2.136. PMID: 30892435

Influence of functional variants Asp312Asn and Lys751Gln of Xeroderma Pigmentosum Group D (XPD) and Glutathione S-transferase Mu 1 (GSTM1) and Theta 1 (GSTT1) genes on cutaneous melanoma susceptibility and prognosis

Rinck-Junior JA, Torricelli C, Gomez GVB, Oliveira C, Moraes AM, Lourenço GJ, Lima CSP.

Exp Dermatol. 2019 May;28(5):631-635. doi: 10.1111/exd.13914. PMID: 30883948

Cost-minimization analysis of GSTP1 c.313A>G genotyping for the prevention of cisplatin-induced nausea and vomiting: A Bayesian inference approach

Macedo LT, Ferrari VE, Carron J, Costa EFD, Lopes-Aguiar L, Lourenço GJ, Lima CSP.

PLoS One. 2019 Mar 14;14(3):e0213929. doi:10.1371/journal.pone.0213929. PMID: 30870506